Picard Medical, Inc. Common Stock
Key Metrics
Market Snapshot
About
Picard Medical, Inc. Common Stock (PMI) is a medical device company that designs, manufactures, produces, supplies, markets, and sells medical device products through its subsidiaries. Incorporated in 2021 and headquartered in Tucson, Arizona, it operates as a subsidiary of Hunniwell Picard I, Llc. The company is best known for its work in advanced cardiac support devices.
Its central product is the SynCardia TAH, a total artificial heart. The device is designed to take over the function of a failed human heart in patients suffering from advanced heart failure. This positions the company in a specialized part of the medical device field, where the goal is to support or replace heart function for patients with severe cardiac conditions rather than to offer routine or general-purpose equipment.
Picard Medical reaches patients across several regions, with operations in the United States, Europe, and other international markets. By manufacturing and selling the SynCardia TAH in these areas, the company serves hospitals and clinical teams that treat people with advanced heart failure and that may use an artificial heart as part of their care.
Because its business is concentrated on a high-acuity cardiac device, Picard Medical, Inc. depends on the design, production, and distribution of the artificial heart and on its acceptance among the medical centers that treat advanced heart failure. Its base in Tucson, Arizona, and its relationship with parent company Hunniwell Picard I, Llc shape its corporate structure, while its international footprint reflects an effort to make the device available to patients beyond a single market.